Shilpa Nirula Board Membership
About Shilpa Nirula
- Shilpa Shridhar Divekar was appointed as an Additional Director of Astrazeneca Pharma India Ltd on December 29, 2021, and subsequently confirmed as an Independent Director for a term of five consecutive years, from December 29, 2021, to December 28, 2026.
- She serves as the Chairperson of the Audit Committee, contributing significantly to the company's governance and oversight functions.
List of Companies Associated with Shilpa Nirula
| Company Name |  Position Held |
|---|---|
| Astrazeneca Pharma India Ltd | Non-Exec. & Independent Dir. |
Historical Share Prices
Shilpa Nirula Sector Specific Experience
About Shilpa Nirula's Work Experience
- Shilpa Nirula is currently a Non-Exec. & Independent Dir. in Astrazeneca Pharma India Ltd (as of Mar 2024).
- Shilpa Nirula is serving the company - Astrazeneca Pharma India Ltd at this position since 2023 for the last 4+ years.
- Prior to becoming Non-Exec. & Independent Dir., Shilpa Nirula was Independent Director of GMM Pfaudler Ltd for 1 year in 2024.
- Before becoming Independent Director, Shilpa Nirula was Additional Director of Astrazeneca Pharma India Ltd for 1 year in 2021.
FAQ's related Shilpa Nirula
Who is Shilpa Nirula
Shilpa Shridhar Divekar was appointed as an Additional Director of Astrazeneca Pharma India Ltd on December 29, 2021, and subsequently confirmed as an Independent Director for a term of five consecutive years, from December 29, 2021, to December 28, 2026. She serves as the Chairperson of the Audit Committee, contributing significantly to the company's governance and oversight functions.
Which companies does Shilpa Nirula serve as a board member for?
Shilpa Nirula serves as a board member for: Astrazeneca Pharma India Ltd,GMM Pfaudler Ltd
What positions has Shilpa Nirula held in his/her career?
Throughout their career, Shilpa Nirula has held key positions such as Non-Exec. & Independent Dir.,Independent Director,Additional Director, contributing to the growth and success of each company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
